Description |
coagulation factor X |
plasminogen |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Antihemophilic factor, human recombinant
- Coagulation factor VIIa Recombinant Human
- Coagulation Factor IX (Recombinant)
- Fondaparinux
- Heparin
- Enoxaparin
- gamma-carboxy-L-glutamic acid
- 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE
- SSR-126517E
- LY-517717
- Rivaroxaban
- Lanoteplase
- Idraparinux
- rNAPc2
- Apixaban
- Otamixaban
- Eribaxaban
- (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE
- THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE
- 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE
- GW-813893
- 2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE
- N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE
- N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE
- N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
- 5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE
- 5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE
- 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE
- 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE
- 5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide
- 5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide
- 5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide
- N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE
- 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE
- 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE
- 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE
- 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE
- THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE
- 3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
- 4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE
- 4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
- 4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE
- 1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE
- Edoxaban
- Turoctocog alfa
- Protamine sulfate
- Bemiparin
- Kappadione
- Antithrombin Alfa
- Betrixaban
- Nafamostat
- Protein S human
- Coagulation factor VII human
- Anti-inhibitor coagulant complex
- Coagulation Factor IX Human
- Antihemophilic factor human
- Albutrepenonacog alfa
- Emicizumab
- Nonacog beta pegol
- Lonoctocog alfa
- Moroctocog alfa
- Turoctocog alfa pegol
|
|
Diseases |
|
|
GWAS |
|
- Aging ( 22773346)
- Blood protein levels ( 29875488 28240269)
- Body mass index ( 26426971)
- Body mass index (age>50) ( 26426971)
- Body mass index x sex x age interaction (4df test) ( 26426971)
- Childhood ear infection ( 27182965 28928442)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Coronary artery disease ( 26343387 33020668)
- Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) ( 28714975)
- End stage renal disease x APOL1 genotype interaction ( 29885931)
- Giant cell arteritis ( 28041642)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Lipoprotein (a) levels ( 26377243)
- Lipoprotein (a) levels in response to niacin in statin-treated individuals ( 30371334)
- Lp (a) levels ( 21900290)
- Myocardial infarction ( 26343387)
- Plasma plasminogen levels ( 25208887)
- Platelet count ( 32888494)
- Triglyceride levels ( 32203549)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
|
Interacting Genes |
21 interacting genes:
APOH
F3
F5
F7
F8
GAD2
GGCX
H1-2
MGST3
NBPF19
NOTCH2NLA
PLAT
PLG
PRKAB1
PROS1
SERPINA10
SERPINA5
SERPINB6
SERPINB8
TFPI
UBQLN2
|
60 interacting genes:
ACTB
AMOT
ANXA2
APOH
ATP5F1B
C7
CDCP1
CHGA
CLEC3B
CP
CPB2
CXCL2
CYFIP2
ENO1
EP300
F10
F2R
F2RL1
F3
FN1
HMGB1
HRG
HSPA1A
HSPB1
HSPD1
IGF2
IGFBP3
KLK3
KNG1
LAMA1
LAMA3
MAPK14
MEP1A
MMP3
MMP7
MMP9
NGF
PAPPA
PCOLCE
PLAT
PLAU
PRDX4
PRNP
RAP2A
RBBP6
RUVBL1
S100A10
SERPINB13
SERPINB6
SERPINC1
SERPINE1
SERPINF2
SERPING1
SERPINI1
SMAD3
SMAD4
SPARC
TFPI2
THBS1
YTHDC1
|
Entrez ID |
2159 |
5340 |
HPRD ID |
01966 |
01417 |
Ensembl ID |
ENSG00000126218
|
ENSG00000122194
|
Uniprot IDs |
P00742
Q5JVE7
Q5JVE8
|
P00747
Q5TEH5
|
PDB IDs |
1C5M
1EZQ
1F0R
1F0S
1FAX
1FJS
1FXY
1G2L
1G2M
1HCG
1IOE
1IQE
1IQF
1IQG
1IQH
1IQI
1IQJ
1IQK
1IQL
1IQM
1IQN
1KSN
1LPG
1LPK
1LPZ
1LQD
1MQ5
1MQ6
1MSX
1NFU
1NFW
1NFX
1NFY
1NL8
1P0S
1V3X
1WU1
1XKA
1XKB
1Z6E
2BMG
2BOH
2BOK
2BQ6
2BQ7
2BQW
2CJI
2D1J
2EI6
2EI7
2EI8
2FZZ
2G00
2GD4
2H9E
2J2U
2J34
2J38
2J4I
2J94
2J95
2JKH
2P16
2P3F
2P3T
2P3U
2P93
2P94
2P95
2PHB
2PR3
2Q1J
2RA0
2UWL
2UWO
2UWP
2VH0
2VH6
2VVC
2VVU
2VVV
2VWL
2VWM
2VWN
2VWO
2W26
2W3I
2W3K
2WYG
2WYJ
2XBV
2XBW
2XBX
2XBY
2XC0
2XC4
2XC5
2Y5F
2Y5G
2Y5H
2Y7X
2Y7Z
2Y80
2Y81
2Y82
3CEN
3CS7
3ENS
3FFG
3HPT
3IIT
3K9X
3KL6
3KQB
3KQC
3KQD
3KQE
3LIW
3M36
3M37
3Q3K
3SW2
3TK5
3TK6
4A7I
4BTI
4BTT
4BTU
4Y6D
4Y71
4Y76
4Y79
4Y7A
4Y7B
4ZH8
4ZHA
5JQY
5JTC
5JZ8
5JZU
5K0H
5VOE
5VOF
6Q9F
6Q9I
6RK9
|
1B2I
1BML
1BUI
1CEA
1CEB
1DDJ
1HPJ
1HPK
1I5K
1KI0
1KRN
1L4D
1L4Z
1PK4
1PKR
1PMK
1QRZ
1RJX
2DOH
2DOI
2KNF
2L0S
2PK4
3UIR
4A5T
4CIK
4DCB
4DUR
4DUU
5HPG
5UGD
5UGG
6D3X
6D3Y
6D3Z
6D40
6OG4
6OQJ
6OQK
6Q1U
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|